Active — Not RecruitingNot Applicable

Investigation of the Effect of Hyperbaric Oxygen Therapy in Patients With Avascular Necrosis

Turkey (Türkiye)20 participantsStarted 2025-08-19

Plain-language summary

Avascular necrosis is a condition that occurs when bone tissue loses sufficient blood flow. This condition causes bone cells to die and, as a result, bone structure to deteriorate. Hyperbaric oxygen therapy is a treatment method used in patients with avascular necrosis. Avascular necrosis can significantly affect the quality of life of patients. The aim of this study was to investigate the effects of hyperbaric oxygen therapy on physical capacity, depressive symptoms, and quality of life in patients diagnosed with avascular necrosis.

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Be over 18 years of age, * Receive hyperbaric treatment, * Be diagnosed with avascular necrosis, * Have stage 1-2 avascular necrosis according to the Ficat classification, * Be able to understand and speak Turkish, * Be able to read and write, Exclusion Criteria: * Having undergone orthopedic surgery on the lower extremities, * Having cardio-respiratory failure that prevents walking, * Having a disorder related to the musculoskeletal system other than AVN * Having a diagnosis of avascular necrosis classified as stage 3-4 according to the Ficat classification * Presence of varicose veins, * Presence of urinary stress incontinence, * Presence of systemic or rheumatological disease, * Pregnancy, * Refusal to participate in the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

tinetti performance oriented mobility assessment measure

Timeframe: 1 week

Beck Depression Inventory

Timeframe: 1 week

Short form 36

Timeframe: 1 week

Trial details

NCT IDNCT07142018

SponsorDr. Lutfi Kirdar Kartal Training and Research Hospital

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2025-08-25

View on ClinicalTrials.gov More Avascular Necrosis of Femur Head trials

Plain-language summary

Who can participate

Age range

18 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.